Dr. Inbar Fischer was awarded a Fulbright postdoctoral fellowship to pursue her research project titled “Bioengineered System for Disease Mechanisms and Personalized Medicine”. In her research, Inbar will develop a microfluidic organ-on-a-chip platform that integrates healthy and diseased human 3D organ models within a single interconnected system. This platform will enable the identification of the tissue of origin and underlying mechanisms of complex diseases by modeling early disease progression and cross-tissue interactions. As a proof of concept, she will focus on amyotrophic lateral sclerosis (ALS), aiming to pinpoint the disease’s origin and identify effective therapeutic strategies.

During her PhD at Tel Aviv University, under the supervision of Professor Boaz Barak, Inbar investigated the biological mechanisms underlying neurodevelopmental disorders, combining molecular neuroscience with bioengineering approaches. Her work bridges basic research and translational applications, with a focus on developing innovative tools for studying and treating brain disorders.

Fischer, I. Shohat, S., L Bardoogo, Y., Nayak, R., et al. "Shank3 mutation impairs glutamate signaling and myelination in ASD mouse model and human iPSC-derived OPCs". Science Advances, 2024.

Liran, M*., Fischer, I.* (equal contribution), Elboim, M., Rahamim, N., et al. "Long-term excessive alcohol consumption enhances myelination in the mouse nucleus accumbens". Journal of Neuroscience, 2025.

Fischer, I., Shohat, S., Levy, G., Bar, E., et al. "Hyperbaric Oxygen Therapy Alleviates Social Behavior Dysfunction and Neuroinflammation in a Mouse Model for Autism Spectrum Disorders". International Journal of Molecular Sciences, 2022.